ImmuPharma (LON:IMM) Stock Price Down 21.1% - Should You Sell?

Key Points

• ImmuPharma plc shares experienced a significant decline of 21.1%, trading as low as GBX 10.80 ($0.15) before closing at GBX 11.76 ($0.16).
• The company's market capitalization stands at £58.76 million, with a highly negative P/E ratio of -1,321.12 and expectations of earning -339.0000022 earnings per share for the current year.
• ImmuPharma is focused on developing peptide-based therapeutics for autoimmune diseases, including its lead program, P140 (Lupuzor™), which targets Lupus and other related conditions.

ImmuPharma plc (LON:IMM - Get Free Report) traded down 21.1% on Wednesday . The company traded as low as GBX 10.80 ($0.15) and last traded at GBX 11.76 ($0.16). 45,915,910 shares were traded during mid-day trading, an increase of 438% from the average session volume of 8,530,393 shares. The stock had previously closed at GBX 14.90 ($0.20).

ImmuPharma Trading Up 2.9%

The stock's 50 day moving average price is GBX 4.28 and its 200 day moving average price is GBX 3.27. The company has a market capitalization of £62.47 million, a price-to-earnings ratio of -1,404.49 and a beta of 1.53.

ImmuPharma (LON:IMM - Get Free Report) last issued its earnings results on Wednesday, August 6th. The company reported GBX (0.38) earnings per share (EPS) for the quarter. ImmuPharma had a net margin of 3,519.56% and a negative return on equity of 131.41%. On average, research analysts expect that ImmuPharma plc will post -339.0000022 earnings per share for the current year.

About ImmuPharma

ImmuPharma PLC LSE AIM: IMM is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company's portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.